Back to search
Hepatic and Hepatobiliary Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatic and Hepatobiliary Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatic and Hepatobiliary Disorders trials you may qualify forRemote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mort…
MASLD is currently one of the most common chronic non-communicable diseases and the leading cause of liver-related mortality and morbidity, with a rising preval…
This study proposes a single-blind randomized clinical trial designed to evaluate the effects of high-intensity interval training (HIIT) on liver health in adul…
This study aims to evaluate the effects of a diet with even protein distribution plus exercise (Group A) versus a diet with skewed protein distribution plus exe…
Background: \- Noncirrhotic Portal Hypertension (NCPH) is caused by liver diseases that increase pressure in the blood vessels of the liver. It seems to start…
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Jaundice is a frequent medical problem that affects people of all ages. It is important to note that jaundice is not an actual sickness as such itself but rathe…
This prospective observational study aims to evaluate the accuracy of using routine abdominal ultrasound to predict the risk of esophageal variceal bleeding in…
Whether impaired postprandial glucagon suppression in prediabetes and T2DM is an attempt to overcome resistance to glucagon's actions on hepatic AA catabolism,…